Precision BioSciences
IPOPublic · Durham, United States · Founded 2006 · $75.0M raised
- Headquarters
- Durham, North Carolina
- Employees
- 51–200
- Founded
- 2006
- Business Model
- B2B
- Website
- precisionbiosciences.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Venture RoundJun 2022
- Rounds
- 1
- Type
- Public
About
Clinical-stage gene editing company developing in vivo therapies using its proprietary ARCUS genome editing platform.
Summary
Precision BioSciences is a Biotech company based in Durham, United States, founded in 2006. It has raised $75.0M in total across 1 round, most recently a $75.0M Venture Round round in Jun 2022. Investors include Novartis Venture Fund, J.P. Morgan and Goldman Sachs.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.